611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
For Many With Mild Asthma, Popular Rx May Not Work: StudyCleaner Air Linked to Lower Asthma Rates in KidsCholesterol Levels Improving Among U.S. KidsPool Chemicals Harm Thousands Every SummerAre Diets High in Processed Foods a Recipe for Obesity?Lupus Takes Bigger Toll on Longevity for BlacksScientists Spot Unexpected Player in FibromyalgiaAnthrax Is a Risk on Every ContinentAHA News: More Clues to the Genetics Behind an Inherited Cholesterol DisorderSuspect Your Child Has an Ear Infection? There May Soon Be an App for ThatLyme Disease Now a Threat in City Parks Health Tip: Treating a Charley HorseMore Back-to-Back Heat Waves Will Come With Climate ChangeParents, Here's How to Protect Your Child During Measles OutbreaksAHA News: Dangerous Blood Clots May Be the Latest Risk From 'Bad' CholesterolAre You Running Short on Iron?1 in 4 American Workers Struggles With Back PainInjured Lungs Can Be Regenerated for Transplant: StudyKeeping Your Summer Fun on Sound FootingMore Active Lupus Linked to Childhood EventsSigns of Rheumatoid Arthritis Can Show Up Long Before DiagnosisSummer Is Tough for Asthma SufferersHepatitis A Infections Soaring: CDCIs the County You Call Home a Potential Measles Hotspot?'Zap' Ear Clip May Ease A-FibTake Steps to Prevent a StrokeDoes Removing Your Appendix Put You at Risk for Parkinson's?Potentially Blinding Shingles of the Eye on the RisePsoriasis, Mental Ills Can Go Hand in HandAfter Concussions, Some Ex-Athletes Show Key Marker for Brain Disease: StudyWindow for Safe Use of Clot-Buster Widens for Stroke PatientsAn Antibiotic Alternative? Using a Virus to Fight BacteriaDo Adults Need a Measles Booster Shot?Military Tourniquets Might Save Kids' Lives During School ShootingsWell Water's Spillover Effect: Heart Damage?AHA News: Helping Asian-Americans Fight Their Hidden Heart RisksSunscreen Chemicals Enter Bloodstream at Potentially Unsafe Levels: Study'Ringing in the Ears' May Drive Some to the Brink of SuicideBlood Test Might Diagnose Chronic Fatigue SyndromeAsthma Inhalers Incorrectly Used by Most Kids in StudyDevice Helps Doctors Select Lungs for TransplantBenlysta Approved for Children With LupusIn a World First, Drone Delivers Kidney for TransplantHigh Measles Rates Mean Kids, Adults Need Proper Vaccination: CDCParents, Protect Your Kids as Measles Outbreaks SpreadWork Stress, Poor Sleep, High Blood Pressure a Deadly TrioFor Obese People, Commuting by Car Can Be a Killer: StudyHealth Tip: Tick RemovalHalf of Older Dialysis Patients Die Within a Year, Study FindsIs Peanut Allergy 'Immunotherapy' Causing More Harm Than Good?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Study Reaffirms Safety of Hepatitis C Meds in Liver Cancer Patients

HealthDay News
by -- Robert Preidt
Updated: Feb 12th 2019

new article illustration

TUESDAY, Feb. 12, 2019 (HealthDay News) -- It's safe to use antiviral drugs to treat hepatitis C in liver cancer survivors, a new study reports.

The findings contradict previous research suggesting that antiviral drugs might increase these patients' risk of liver cancer recurrence.

That prior research involved a single-center study from Spanish investigators in 2016 that "gained a lot of press and sparked fear about treating liver cancer patients for their hepatitis C," said Dr. Amit Singal. He is medical director of the liver tumor program at UT Southwestern Medical Center, in Dallas.

"Based on these new data, providers can feel reassured that it is safe to treat hepatitis C in these patients and allow them to receive the known benefits of hepatitis C therapy," Singal said in a center news release.

For the new study, researchers examined the medical records of patients who'd been successfully treated for liver cancer at 31 medical centers in North America. The investigators compared liver cancer recurrence in those who were and were not given direct-acting antivirals, such as Harvoni or Sovaldi, for hepatitis C.

The cancer recurrence rates were 42 percent among those who received the antiviral drugs and 59 percent among those who did not receive the medication -- not a significant difference, according to the study authors.

The researchers also said that among patients with a recurrence, there was no difference in cancer aggressiveness between the two groups.

The study was published recently in the journal Gastroenterology.

About 3.2 million people in the United States have chronic hepatitis C infection. Since 2013, effective antiviral drugs have been available to treat it.

Chronic hepatitis C infection is a leading cause of liver cancer, and half of liver cancer patients have underlying chronic hepatitis C infection, according to the U.S. Centers for Disease Control and Prevention.

"Our results suggest that use of direct-acting antiviral therapies is safe and potentially beneficial in hepatitis C-infected patients with a history of liver cancer," Singal concluded.

More information

The American Academy of Family Physicians has more on hepatitis C.